Hashimoto, R., Tanabe, E., Otsuka, Y., Yoneda, Y., & Kageyama, Y. (2021). Anti-Ma2-Associated Limbic Encephalitis after Termination of Immune Checkpoint Inhibitor Therapy for Malignant Pleural Mesothelioma. Karger Publishers.
Cita Chicago Style (17a ed.)Hashimoto, Rei, Etsuko Tanabe, Yoshihisa Otsuka, Yukihiro Yoneda, y Yasufumi Kageyama. Anti-Ma2-Associated Limbic Encephalitis After Termination of Immune Checkpoint Inhibitor Therapy for Malignant Pleural Mesothelioma. Karger Publishers, 2021.
Cita MLA (8a ed.)Hashimoto, Rei, et al. Anti-Ma2-Associated Limbic Encephalitis After Termination of Immune Checkpoint Inhibitor Therapy for Malignant Pleural Mesothelioma. Karger Publishers, 2021.
Precaución: Estas citas no son 100% exactas.